Hikma, a pharmaceutical company, agreed to acquire pharmaceutical and consumer businesses in Egypt and pharmaceutical business in Tunisia from GlaxoSmithKline, a global healthcare company. Financial terms were not disclosed. The Proposed Transaction is subject to a number of conditions, including the finalisation of definitive and legally binding documents and the completion of due diligence by Hikma.